新的艾滋病毒预防镜头显示效果很高,但拉丁美洲对获得治疗的担忧迫在眉睫。 New HIV prevention shot shows high efficacy, but access concerns loom for Latin America.
新的一年两次的艾滋病毒预防针头Lenacapavir(Sunlenca)显示,在妇女预防艾滋病毒方面几乎非常有效,在男子中几乎同样有效。 A new twice-yearly HIV prevention shot, lenacapavir (Sunlenca), shows near-perfect effectiveness in preventing HIV in women and nearly as effective in men. Gilead -- -- 毒品制造者 -- -- 计划为预防工作寻求授权,并同意在120个低收入国家允许廉价非专利药品。 Gilead, the drugmaker, plans to seek authorization for its use in prevention and has agreed to allow cheap generics in 120 low-income countries. 然而,拉丁美洲大部分地区被排除在这一交易之外,使人们担心,尽管那里的感染率在上升,但获得治疗的机会却在增加。 However, most of Latin America is excluded from this deal, raising concerns about access despite rising infection rates there. 这种药物可能对男同性恋者、性工作者和年轻妇女等边缘化群体特别有益。 The drug could be particularly beneficial for marginalized groups like gay men, sex workers, and young women.